Innovative Models for High-Risk Patients Use Care Coordination and Palliative Supports to Reduce End-of-life Utilization and Spending.

Innov Aging · 2017 · PMC6176974 · PMID 30480116

Europe PMC DOI

hedged sentence

0.1000

closest p · 2.0× alpha

0.1000

boldest claim

The sentences

a nonsignificant trendp < .10so close (0.05 < p ≤ 0.1)

BSLTOC had a significantly lower average cost per participant in the last 90 ($2,122; p < .001) and 180 ($2,922; p < .001) days of life relative to the comparison group and a nonsignificant trend toward significantly lower average cost per participant in the last 30 days of life ($861; p < .10) ( Table 3 and Figure 1 ).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.